AIDS, HIV & STDs Research Reports
AIDS Associated Dementia - Pipeline Review, H1 2012 Topics: AIDS, HIV & STDs, Drug Discovery
| AIDS - Related Kaposi's Sarcoma - Pipeline Review, H1 2012 Topics: AIDS, HIV & STDs, Drug Discovery
| AIDS - Related Lymphoma - Pipeline Review, H1 2012 Topics: AIDS, HIV & STDs, Drug Discovery
| HIV-Associated Lipodystrophy Syndrome - Pipeline Review, H1 2012 Topics: AIDS, HIV & STDs, Drug Discovery
| Global HIV/AIDS Testing Market 2010-2014 Topics: AIDS, HIV & STDs, Microbiology & Virology
Regions: Global
| AIDS-Related Opportunistic Infections - Pipeline Review, H2 2011 Topics: AIDS, HIV & STDs
| HIV / AIDS Global Clinical Trials Review, H2, 2011 Topics: AIDS, HIV & STDs, Clinical Trial
| Global HIV Drugs Market 2010-2014 Topics: AIDS, HIV & STDs
Regions: Global
| Competitor Analysis: HIV Small Molecule Therapeutics Topics: AIDS, HIV & STDs, Drug Discovery
| Global HIV Therapeutics Market Analysis Topics: AIDS, HIV & STDs
Regions: Global
| Anal Fissure Global Clinical Trials Review, H2, 2011 Topics: AIDS, HIV & STDs, Drug Discovery
| Chlamydia Infections Global Clinical Trials Review, H2, 2011 Topics: AIDS, HIV & STDs, Drug Discovery
| Syphilis Global Clinical Trials Review, H2, 2011 Topics: AIDS, HIV & STDs, Drug Discovery
| Chlamydia Infections - Pipeline Review, H2 2011 Topics: AIDS, HIV & STDs, Drug Discovery, Women's Health, Men's Health
| HIV Pain - Pipeline Review, H2 2011 Topics: AIDS, HIV & STDs, Drug Discovery
| Herpes Labialis (Oral Herpes) - Pipeline Review, H2 2011 Topics: AIDS, HIV & STDs, Drug Discovery, Dentistry/Oral
| Global HIV/AIDS Diagnostics Market: Growth Opportunities and Business Expansion Strategies Topics: AIDS, HIV & STDs, Microbiology & Virology
| HIV/AIDS Statistics in the Republic of South Africa (RSA): An Analysis of HIV/AIDS Mortality Comparing Death Counts, Surveillance Data, and Modeled Estimates Topics: AIDS, HIV & STDs
Regions: South Africa
| HIV Drugs Market in India 2010-2014 Topics: AIDS, HIV & STDs
Regions: India
| HIV/AIDS Therapeutics Market to 2017 - Superior Combination Therapies and Decreasing Mortality to Sustain Market Growth Despite Major Patent Expiries Topics: AIDS, HIV & STDs
| Special Report: Evolving Patterns and Unmet Needs in the TB Population in Developing and Developed Markets Topics: AIDS, HIV & STDs, Tuberculosis, Prescription Drugs, Drug Discovery
| Competitor Analysis: HIV Vaccines Topics: AIDS, HIV & STDs, Vaccines
| Herpes Simplex Infections - Pipeline Review, H2 2011 Topics: AIDS, HIV & STDs
| Herpes Zoster (Shingles) - Pipeline Review, H2 2011 Topics: AIDS, HIV & STDs, Drug Discovery
| HIV / AIDS - Pipeline Review, H2 2011 Topics: AIDS, HIV & STDs, Drug Discovery
| HIV-1 Infection - Pipeline Review, H2 2011 Topics: AIDS, HIV & STDs, Drug Discovery
| Genital Herpes - Pipeline Review, H2 2011 Topics: AIDS, HIV & STDs
| Herpes Simplex Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Topics: AIDS, HIV & STDs, Drug Discovery, Reproductive Health
| AIDS - Related Cancers - Pipeline Review, H2 2011 Topics: AIDS, HIV & STDs, Drug Discovery, Oncology/Hematology
| Gilead's newly approved drug Complera, the Second Triple Combination Once-a-Day Pill Intended for Untreated HIV Patients is unlikely to displace its own market-leading drug, Atripla Topics: AIDS, HIV & STDs, Prescription Drugs
| The HIV Market Outlook to 2016 Topics: AIDS, HIV & STDs
| HIV-Associated Lipodystrophy Syndrome - Pipeline Review, Q3 2011 Topics: AIDS, HIV & STDs
| AIDS-Related Kaposi's Sarcoma - Pipeline Review, Q3 2011 Topics: AIDS, HIV & STDs, Oncology/Hematology
| AIDS Associated Dementia - Pipeline Review, Q3 2011 Topics: AIDS, HIV & STDs, Drug Discovery
| Aids - Related Lymphoma - Pipeline Review, Q3 2011 Topics: AIDS, HIV & STDs, Drug Discovery
| Epidemiology: HIV - Antiretrovirals prevail as patient population grows Topics: AIDS, HIV & STDs
| Molecular Diagnostics in Infectious Disease Testing Topics: Genomics, Proteomics, AIDS, HIV & STDs, Hepatitis, Molecular Diagnostics, Infectious Diseases
| HIV-Associated Lipodystrophy Therapeutics - Pipeline Assessment and Market Forecasts to 2017 Topics: AIDS, HIV & STDs
| AIDS-Related Opportunistic Infections - Pipeline Review, Q2 2011 Topics: AIDS, HIV & STDs, Drug Discovery
| HIV-1 Infection Global Clinical Trials Review, Q2, 2011 Topics: AIDS, HIV & STDs
| Key Companies: HIV - Companies co-operate and co-formulate to stay competitive in a tight HIV market Topics: AIDS, HIV & STDs
| AIDS-related Kaposi's Sarcoma (ARKS) Therapeutics - Pipeline Assessment and Market Forecasts to 2017 Topics: AIDS, HIV & STDs, Research & Development
| AIDS-Related Kaposi's Sarcoma (ARKS) Therapeutics -Pipeline Assessment and Market Forecasts to 2017 Topics: AIDS, HIV & STDs
| Transfusion Diagnostic Testing Market: US, Europe, Japan--Emerging Opportunities And Business Expansion Strategies for Suppliers Topics: AIDS, HIV & STDs, Hepatitis, Blood Banking & Tissue Typing, Histology & Cytology
Regions: Japan, United States, Europe
| Genital Herpes Therapeutics - Pipeline Assessment and Market Forecasts to 2017 Topics: AIDS, HIV & STDs
| Herpes Labialis (Oral Herpes) - Pipeline Review, Q2 2011 Topics: AIDS, HIV & STDs
| HIV Pain - Pipeline Review, Q2 2011 Topics: AIDS, HIV & STDs, Drug Discovery
| Chlamydia Infections - Pipeline Review, Q2 2011 Topics: AIDS, HIV & STDs, Drug Discovery
| Specialty Pharmaceutical Industry - 2011 Yearbook Topics: AIDS, HIV & STDs, Pharmaceuticals Company Reports, Manufacturing, Packaging & Detailing, Research & Development, Prescription Drugs, Rheumatology/Arthritis
| HIV-AIDS Therapeutics - Pipeline Assessment and Market Forecasts to 2017 Topics: AIDS, HIV & STDs
|
Prev | 1 | 2 | 3 | 4 | Next
|
|
|
About MarketResearch.com
MarketResearch.com is an online aggregator selling over 300,000 market research reports, company profiles and country profiles from over 700 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.
© MarketResearch.com 2012
|